129 related articles for article (PubMed ID: 10604483)
21. [Uncontrolled arterial hypertension: pharmaco-economic interest of hospital diagnostic work-up].
Ragot S; Sosner P; Herpin D
Arch Mal Coeur Vaiss; 2002; 95(7-8):733-7. PubMed ID: 12365089
[TBL] [Abstract][Full Text] [Related]
22. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[TBL] [Abstract][Full Text] [Related]
23. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
24. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
[TBL] [Abstract][Full Text] [Related]
25. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
[TBL] [Abstract][Full Text] [Related]
26. Aldosterone and refractory hypertension: a prospective cohort study.
Sartori M; Calò LA; Mascagna V; Realdi A; Macchini L; Ciccariello L; De Toni R; Cattelan F; Pessina AC; Semplicini A
Am J Hypertens; 2006 Apr; 19(4):373-9; discussion 380. PubMed ID: 16580572
[TBL] [Abstract][Full Text] [Related]
27. [Primary hyperaldosteronism. Not an exotic cause of hypertension].
Füessl HS
MMW Fortschr Med; 2006 Nov; 148(45):37, 39-40. PubMed ID: 17615747
[No Abstract] [Full Text] [Related]
28. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
29. [Hypertension 2007-2008].
Chatzikyrkou C; Menne J; Haller H
Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
[TBL] [Abstract][Full Text] [Related]
30. Congenital adrenal hyperplasia 11beta-hydroxylase deficiency: two cases managed with bilateral adrenalectomy.
John M; Menon SK; Shah NS; Menon PS
Singapore Med J; 2009 Feb; 50(2):e68-70. PubMed ID: 19296015
[TBL] [Abstract][Full Text] [Related]
31. [New differential diagnostic and therapeutic possibilities in arterial hypertension].
Gogin EE; Gerasimov GM; Martyniuk AD
Klin Med (Mosk); 1978 Oct; 56(10):30-5. PubMed ID: 713456
[No Abstract] [Full Text] [Related]
32. [Anesthesia and intensive care problems in adrenocortical surgery].
Proye C; Scherpereel P; Sonnenfeld H
Anesth Analg (Paris); 1978; 35(2):251-62. PubMed ID: 697064
[No Abstract] [Full Text] [Related]
33. The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.
Rydén L; Waeber B; Ruilope LM; Mancia G; Volpe M; Holzgreve H; Mogensen CE; Laurent S
Blood Press; 2008; 17(5-6):250-9. PubMed ID: 19012063
[TBL] [Abstract][Full Text] [Related]
34. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
35. [Long-term ambulatory follow-up of hypertension patients with low renin activity in blood].
Iurenev AP; Patrusheva IF
Ter Arkh; 2002; 74(9):57-9. PubMed ID: 12418122
[TBL] [Abstract][Full Text] [Related]
36. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
37. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism.
Sywak M; Pasieka JL
Br J Surg; 2002 Dec; 89(12):1587-93. PubMed ID: 12445071
[TBL] [Abstract][Full Text] [Related]
39. Aliskiren: the first renin inhibitor for clinical treatment.
Jensen C; Herold P; Brunner HR
Nat Rev Drug Discov; 2008 May; 7(5):399-410. PubMed ID: 18340340
[TBL] [Abstract][Full Text] [Related]
40. Use of noninvasive hemodynamics in hypertension management.
Sanford T; Treister N; Peters C
Am J Hypertens; 2005 Feb; 18(2 Pt 2):87S-91S. PubMed ID: 15752938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
